According to the latest Market Watch forecast, the Chilean pharmaceutical market has grown by a robust 14.8% in US dollar terms in 2008 and by 9.2% in local currency terms. The report, which is mainly upbeat, concludes on a depressing note for IP:
"Whatever the challenges facing the current government, Chile remains a relative oasis of clean governance, stability and economic openness and has ratified Free-Trade Agreement (FTA) with the US. Nonetheless, for the research-based pharmaceutical industry, the intellectual property (IP) environment remains deficient".
